Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2100.53 | 459 / 459 | 100% | 24.35 | 1118 / 1118 |
esophagus | 100% | 1576.95 | 1445 / 1445 | 100% | 17.41 | 183 / 183 |
liver | 100% | 2320.22 | 226 / 226 | 100% | 17.19 | 406 / 406 |
lung | 100% | 1847.98 | 578 / 578 | 100% | 20.17 | 1155 / 1155 |
ovary | 100% | 2125.31 | 180 / 180 | 100% | 17.44 | 430 / 430 |
pancreas | 100% | 2493.11 | 328 / 328 | 100% | 18.51 | 178 / 178 |
prostate | 100% | 2369.31 | 245 / 245 | 100% | 28.79 | 502 / 502 |
skin | 100% | 1985.34 | 1809 / 1809 | 100% | 22.62 | 472 / 472 |
thymus | 100% | 2550.88 | 653 / 653 | 100% | 26.57 | 605 / 605 |
uterus | 100% | 2053.56 | 170 / 170 | 100% | 24.21 | 459 / 459 |
kidney | 100% | 1958.82 | 89 / 89 | 100% | 22.13 | 899 / 901 |
bladder | 100% | 1836.43 | 21 / 21 | 100% | 19.13 | 502 / 504 |
brain | 100% | 1223.35 | 2631 / 2642 | 100% | 22.11 | 705 / 705 |
adrenal gland | 100% | 2605.55 | 258 / 258 | 99% | 17.25 | 228 / 230 |
stomach | 100% | 1788.22 | 359 / 359 | 99% | 14.61 | 283 / 286 |
intestine | 100% | 1747.14 | 966 / 966 | 99% | 14.34 | 520 / 527 |
adipose | 100% | 1995.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.07 | 29 / 29 |
spleen | 100% | 2681.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.39 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.21 | 1 / 1 |
blood vessel | 100% | 1616.29 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1021.74 | 857 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 935.76 | 796 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 16.98 | 79 / 80 |
peripheral blood | 98% | 1692.67 | 907 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_1904153 | Biological process | negative regulation of retrograde protein transport, ER to cytosol |
GO_0030970 | Biological process | retrograde protein transport, ER to cytosol |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0036503 | Biological process | ERAD pathway |
GO_0001967 | Biological process | suckling behavior |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005770 | Cellular component | late endosome |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005769 | Cellular component | early endosome |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005047 | Molecular function | signal recognition particle binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DERL2 |
Protein name | Derlin 2 Derlin Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa) |
Synonyms | CGI-101 SBBI53 FLANA DER2 |
Description | FUNCTION: Functional component of endoplasmic reticulum-associated degradation (ERAD) for misfolded lumenal glycoproteins, but not that of misfolded nonglycoproteins. May act by forming a channel that allows the retrotranslocation of misfolded glycoproteins into the cytosol where they are ubiquitinated and degraded by the proteasome. May mediate the interaction between VCP and misfolded glycoproteins . May also be involved in endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation . .; FUNCTION: (Microbial infection) In contrast to DERL1, it is not involved in the degradation of MHC class I heavy chains following infection by cytomegaloviruses. . FUNCTION: Functional component of endoplasmic reticulum-associated degradation (ERAD) for misfolded lumenal proteins. May act by forming a channel that allows the retrotranslocation of misfolded proteins into the cytosol where they are ubiquitinated and degraded by the proteasome. . FUNCTION: Functional component of endoplasmic reticulum-associated degradation (ERAD) for misfolded lumenal proteins. May act by forming a channel that allows the retrotranslocation of misfolded proteins into the cytosol where they are ubiquitinated and degraded by the proteasome. . FUNCTION: Functional component of endoplasmic reticulum-associated degradation (ERAD) for misfolded lumenal proteins. May act by forming a channel that allows the retrotranslocation of misfolded proteins into the cytosol where they are ubiquitinated and degraded by the proteasome. . |
Accessions | I3L0R8 ENST00000573637.5 ENST00000571971.1 I3L1S8 ENST00000574952.5 ENST00000575605.5 ENST00000570848.5 ENST00000572834.5 ENST00000576551.5 ENST00000158771.9 ENST00000571476.5 I3L1W3 Q9GZP9 K7EQE8 I3L4W7 I3L1T3 I3L3R8 |